Barbiturate toxicity: Difference between revisions
(Text replacement - " CV " to " cardiovascular ") |
|||
| (10 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Death most commonly due to respiratory arrest and | *Death most commonly due to respiratory arrest and cardiovascular collapse | ||
*Assume severe poisoning if >10x hypnotic dose has been ingested | *Assume severe poisoning if >10x hypnotic dose has been ingested | ||
| Line 13: | Line 13: | ||
*Coma, absence of corneal reflex | *Coma, absence of corneal reflex | ||
== | ==Differential Diagnosis== | ||
{{Sedatve/hypnotic toxicity types}} | |||
==Evaluation== | |||
==Management== | |||
#Airway assessment and stabilization | #Airway assessment and stabilization | ||
#*Mechanical ventilation often required | #*Mechanical ventilation often required | ||
| Line 22: | Line 27: | ||
#*Rewarming measures | #*Rewarming measures | ||
#GI Decontamination | #GI Decontamination | ||
#*[[Activated charcoal]] x1 if present | #*[[Activated charcoal]] x1 if present within 1hr of ingestion | ||
#*[[Multi-dose activated charcoal]] | #*[[Multi-dose activated charcoal]] | ||
#**Consider only if | #**Consider only if patient has ingested life-threatening amount of phenobarbital | ||
#**Give 50-100gm PO initially; follow by 12.5-25gm PO q4hr | #**Give 50-100gm PO initially; follow by 12.5-25gm PO q4hr | ||
#[[Urinary alkalinization]] | #[[Urinary alkalinization]] | ||
| Line 33: | Line 38: | ||
==Disposition== | ==Disposition== | ||
*Consider discharge if improvement in neuro status / | *Consider discharge if improvement in neuro status / vital signs over 6-8hr | ||
*Evidence of toxicity after 6hr requires admission | *Evidence of toxicity after 6hr requires admission | ||
| Line 39: | Line 44: | ||
*[[Sedative/Hypnotic]] | *[[Sedative/Hypnotic]] | ||
== | ==References== | ||
<references/> | |||
[[Category: | [[Category:Toxicology]] | ||
Latest revision as of 11:49, 24 September 2016
Background
- Death most commonly due to respiratory arrest and cardiovascular collapse
- Assume severe poisoning if >10x hypnotic dose has been ingested
Clinical Features
Mild-moderate toxicity
- Resembles ETOH intoxication
Severe toxicity
- Respiratory depression
- Hypothermia
- Hypotension (decreased vascular tone)
- Coma, absence of corneal reflex
Differential Diagnosis
Sedative/hypnotic toxicity
- Absinthe
- Barbiturates
- Benzodiazepines
- Chloral hydrate
- Gamma hydroxybutyrate (GHB)
- Baclofen toxicity
- Opioids
- Toxic alcohols
- Xylazine toxicity
Evaluation
Management
- Airway assessment and stabilization
- Mechanical ventilation often required
- Hypotension
- IVF
- Dopamine or norepinepherine
- Hypothermia
- Rewarming measures
- GI Decontamination
- Activated charcoal x1 if present within 1hr of ingestion
- Multi-dose activated charcoal
- Consider only if patient has ingested life-threatening amount of phenobarbital
- Give 50-100gm PO initially; follow by 12.5-25gm PO q4hr
- Urinary alkalinization
- Less effective than multi-dose activated charcoal
- Dialysis
- Only effective for phenobarbital (long-acting barb)
- Reserved for patients who are deteriorating despite aggressive supportive care
Disposition
- Consider discharge if improvement in neuro status / vital signs over 6-8hr
- Evidence of toxicity after 6hr requires admission